Therapixel Case Study: Improved Radiologist Performance with MammoScreen 3D

Ferrum Health partners with best-in-class AI providers offering solutions designed to reduce radiology workload and improve patient care.Therapixel Case Study: Improved Radiologist PerformanceIntroductionOne in eight women will develop breast cancer in their lifetime. Early detection of breast cancer is key before the cancer metastasizes. A clinical study compared radiologists' performance reading with and without MammoScreen® 3D.Clinical caseAfter a false negative case, the original reader found the cancer a year after the initial mammogram. A linear microcalcification cluster in the posterior medial right breast was detected. The lesion was flagged by MammoScreen via tomosynthesis a year earlier with a score of 7. During a reader study, 5 radiologists recalled this case unassisted, with an additional 12 recalling the case utilizing MammoScreen.

ConclusionThe Therapixel Study suggests the use of AI-guided decision-making support, such as Mammoscreen, is reliable in assisting in the early detection of breast cancer.Interested in deploying Mammoscreen at your health facility?Contact the Ferrum Health team to learn more.